scholarly journals Dynamic Handwriting Analysis for Supporting Earlier Parkinson’s Disease Diagnosis

Information ◽  
2018 ◽  
Vol 9 (10) ◽  
pp. 247 ◽  
Author(s):  
Donato Impedovo ◽  
Giuseppe Pirlo ◽  
Gennaro Vessio

Machine learning techniques are tailored to build intelligent systems to support clinicians at the point of care. In particular, they can complement standard clinical evaluations for the assessment of early signs and manifestations of Parkinson’s disease (PD). Patients suffering from PD typically exhibit impairments of previously learned motor skills, such as handwriting. Therefore, handwriting can be considered a powerful marker to develop automatized diagnostic tools. In this paper, we investigated if and to which extent dynamic features of the handwriting process can support PD diagnosis at earlier stages. To this end, a subset of the publicly available PaHaW dataset has been used, including those patients showing only early to mild degree of disease severity. We developed a classification framework based on different classifiers and an ensemble scheme. Some encouraging results have been obtained; in particular, good specificity performances have been observed. This indicates that a handwriting-based decision support tool could be used to administer screening tests useful for ruling in disease.

Sensors ◽  
2020 ◽  
Vol 20 (9) ◽  
pp. 2630 ◽  
Author(s):  
Erika Rovini ◽  
Carlo Maremmani ◽  
Filippo Cavallo

Objective assessment of the motor evaluation test for Parkinson’s disease (PD) diagnosis is an open issue both for clinical and technical experts since it could improve current clinical practice with benefits both for patients and healthcare systems. In this work, a wearable system composed of four inertial devices (two SensHand and two SensFoot), and related processing algorithms for extracting parameters from limbs motion was tested on 40 healthy subjects and 40 PD patients. Seventy-eight and 96 kinematic parameters were measured from lower and upper limbs, respectively. Statistical and correlation analysis allowed to define four datasets that were used to train and test five supervised learning classifiers. Excellent discrimination between the two groups was obtained with all the classifiers (average accuracy ranging from 0.936 to 0.960) and all the datasets (average accuracy ranging from 0.953 to 0.966), over three conditions that included parameters derived from lower, upper or all limbs. The best performances (accuracy = 1.00) were obtained when classifying all the limbs with linear support vector machine (SVM) or gaussian SVM. Even if further studies should be done, the current results are strongly promising to improve this system as a support tool for clinicians in objectifying PD diagnosis and monitoring.


Author(s):  
Yareth Gopar-Cuevas ◽  
Ana P. Duarte-Jurado ◽  
Rosa N. Diaz-Perez ◽  
Odila Saucedo-Cardenas ◽  
Maria J. Loera-Arias ◽  
...  

Metabolites ◽  
2020 ◽  
Vol 11 (1) ◽  
pp. 14
Author(s):  
Petr G. Lokhov ◽  
Dmitry L. Maslov ◽  
Steven Lichtenberg ◽  
Oxana P. Trifonova ◽  
Elena E. Balashova

A laboratory-developed test (LDT) is a type of in vitro diagnostic test that is developed and used within a single laboratory. The holistic metabolomic LDT integrating the currently available data on human metabolic pathways, changes in the concentrations of low-molecular-weight compounds in the human blood during diseases and other conditions, and their prevalent location in the body was developed. That is, the LDT uses all of the accumulated metabolic data relevant for disease diagnosis and high-resolution mass spectrometry with data processing by in-house software. In this study, the LDT was applied to diagnose early-stage Parkinson’s disease (PD), which currently lacks available laboratory tests. The use of the LDT for blood plasma samples confirmed its ability for such diagnostics with 73% accuracy. The diagnosis was based on relevant data, such as the detection of overrepresented metabolite sets associated with PD and other neurodegenerative diseases. Additionally, the ability of the LDT to detect normal composition of low-molecular-weight compounds in blood was demonstrated, thus providing a definition of healthy at the molecular level. This LDT approach as a screening tool can be used for the further widespread testing for other diseases, since ‘omics’ tests, to which the metabolomic LDT belongs, cover a variety of them.


2021 ◽  
Author(s):  
Shengfang Song ◽  
Zhehui Luo ◽  
Chenxi Li ◽  
Xuemei Huang ◽  
Eric J. Shiroma ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document